This document discusses complaints and recalls procedures according to Good Manufacturing Practices. It outlines the objectives of handling complaints and recalls, including identifying key issues and understanding specific requirements. The document describes complaint procedures such as designating responsible personnel, written procedures, investigations, and record keeping. It also describes recall procedures including reasons, definitions, responsible personnel, standard operating procedures, distribution records, and effectiveness testing. Classification of defects and root cause analysis are also discussed.
Self-inspection should be carried out in order to verify compliance by the enterprise with the requirements of these Rules and suggest the necessary corrective actions.
Handling of Customer Complaint_Dr.A.AmsavelDr. Amsavel A
Reference Guideline
Definitions
GMP Requirement: 21 CFR § 211.198 and ICH Q7
Procedure for Handling of Complaints
Complaint Investigation
Remedial action and CAPA
Report preparation
Response to customer
Verification of CAPA effectiveness
Review of Complaints
Self-inspection should be carried out in order to verify compliance by the enterprise with the requirements of these Rules and suggest the necessary corrective actions.
Handling of Customer Complaint_Dr.A.AmsavelDr. Amsavel A
Reference Guideline
Definitions
GMP Requirement: 21 CFR § 211.198 and ICH Q7
Procedure for Handling of Complaints
Complaint Investigation
Remedial action and CAPA
Report preparation
Response to customer
Verification of CAPA effectiveness
Review of Complaints
Role of quality systems and audits in pharmaceutical manufacturing environmentMalay Pandya
By regulation, appropriate practice, and common sense, quality assurance (QA) is a critical function in the pharmaceutical manufacturing environment. The need for an independent unit to audit and comment on the appropriate application of standard operating procedures, master batch records, procedures approved in product applications, and the proper functioning of the quality control (QC) unit is paramount.
This helps assure that products are manufactured reliably, with adherence to approved specifications, and that current good manufacturing practices (cGMP) are maintained in conformance to regulation, both in the facility in general and the microenvironment of each product ’s manufacturing sequence.
This presentation is aimed at providing information on automation in the GLP practices in the pharmaceutical industry.
-Standard Operating Procedures.
-Documentation in GALP.
-Logs and Related Forms.
Complaints in Quality Management SystemMayuriMore15
Complaints evaluation and handling, Investigation and Determination, CAPA and Return and Recall of products in Quality Management system in pharmaceutical or any industry.
Site Master File or SMF is a document in the pharmaceutical industry which provides information about the production and control of manufacturing operations. The document is created by a manufacturer.
It's a document prepared by the manufacturer containing specific and factual GMP information about the production and/or control of pharmaceutical manufacturing operations carried out at the named site and any closely integrated operations at adjacent and nearby buildings. If only part of a pharmaceutical operation is carried out on the site, the site master file need describe only those operations, e.g., analysis, packaging.
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
Role of quality systems and audits in pharmaceutical manufacturing environmentMalay Pandya
By regulation, appropriate practice, and common sense, quality assurance (QA) is a critical function in the pharmaceutical manufacturing environment. The need for an independent unit to audit and comment on the appropriate application of standard operating procedures, master batch records, procedures approved in product applications, and the proper functioning of the quality control (QC) unit is paramount.
This helps assure that products are manufactured reliably, with adherence to approved specifications, and that current good manufacturing practices (cGMP) are maintained in conformance to regulation, both in the facility in general and the microenvironment of each product ’s manufacturing sequence.
This presentation is aimed at providing information on automation in the GLP practices in the pharmaceutical industry.
-Standard Operating Procedures.
-Documentation in GALP.
-Logs and Related Forms.
Complaints in Quality Management SystemMayuriMore15
Complaints evaluation and handling, Investigation and Determination, CAPA and Return and Recall of products in Quality Management system in pharmaceutical or any industry.
Site Master File or SMF is a document in the pharmaceutical industry which provides information about the production and control of manufacturing operations. The document is created by a manufacturer.
It's a document prepared by the manufacturer containing specific and factual GMP information about the production and/or control of pharmaceutical manufacturing operations carried out at the named site and any closely integrated operations at adjacent and nearby buildings. If only part of a pharmaceutical operation is carried out on the site, the site master file need describe only those operations, e.g., analysis, packaging.
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
The importance of quality and food safety cannot be neglected in the present business scenario
due to extreme competition in open market. Many food industrialists have understood the
importance of implementation of system that can eliminate non- conformance products, as these
may help the company in preventing negative consequences like economical losses and helps to
protect the reputation of brand. The design of food safety management system for managing
non- conformance in industry may either support or hinder the effectiveness of continuous
improvement policy.
A non-conformance is involved when a process or a system failsto comply with the rules or meet
the required specifications of an audit standard(ISO 22000, IRC, BRC, SQC etc.). A requirement is a need, expectation, or obligation. It can be stated or implied by an organization, its customers,
or other interested parties. There are many types of requirements. Some of these include food
safety requirements, quality requirements, process requirements, product requirements,
customer requirements, management systems requirements, and legal requirements. Whenever
your organization fails to meet one of these requirements, a nonconformity occurs, and it mostly
occurs in the production and manufacturing processes like Supply chain management, inventory,
and material management process etc. It mainly asks for a rework which requires the
involvement of various personnel from the respective departments.
Quality audit is defined as a systematic and independent examination to determine whether activities and related results comply with planned arrangements and whether these arrangements are implemented effectively and are suitable to achieve objectives Quality audit means a systematic examination of a quality system
Quality audits are typically performed at defined intervals
.Definition
Objectives
Difference between Quality audit and Periodic evaluation
Self inspection
Types of Quality Audit
Role OF GMP Audit in QA and QC programmes
Elements of a Systemic Audit program
Dr. V. S. Kashikar
An effective complaint handling system is an extremely important part of any quality system. Manufacturers should understand that any complaint received on a product shall be evaluated and, if necessary, thoroughly investigated and analyzed, and corrective action shall be taken.
Effectiveness of ISO 15189 2012: a requirement for medical laboratories with ...iosrjce
IOSR Journal of Business and Management (IOSR-JBM) is a double blind peer reviewed International Journal that provides rapid publication (within a month) of articles in all areas of business and managemant and its applications. The journal welcomes publications of high quality papers on theoretical developments and practical applications inbusiness and management. Original research papers, state-of-the-art reviews, and high quality technical notes are invited for publications.
An effective complaint handling system is an extremely important part of any quality system. Manufacturers should understand that any complaint received on a product shall be evaluated and, if necessary, thoroughly investigated and analyzed, and corrective action shall be taken. The results of this evaluation should lead to a conclusion regarding whether the complaint was valid, what the root cause of the complaint was, and what action is necessary to prevent further occurrences.
An effective complaint handling system is an extremely important part of any quality system. Manufacturers should understand that any complaint received on a product shall be evaluated and, if necessary, thoroughly investigated and analyzed, and corrective action shall be taken.
Quy trình kiểm soát thay đổi sau khi cấp Giấy chứng nhận GMP/Giấy chứng nhận đủ điều kiện kinh doanh dược đối với cơ sở sản xuất thuốc, nguyên liệu làm thuốc
Quy trình đánh giá đáp ứng “Thực hành tốt sản xuất thuốc, nguyên liệu làm thuốc” (GMP) đối với cơ sở không thuộc diện cấp chứng nhận đủ điều kiện kinh doanh dược
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Complaints and recalls - WHO GMP training
1. Module 5 | Slide 1 of 22 2012
Sections 5 and 6
Basic Principles of GMP
Complaints and Recalls
2. Module 5 | Slide 2 of 22 2012
Complaints and Recalls
Objectives
To identify the key issues in product complaint and recall
handling
To understand the specific requirements for organization,
procedures and resources
To understand and develop actions to resolve current issues
applicable to you
3. Module 5 | Slide 3 of 22 2012
5.1
Complaints and Recalls
Complaints: Principle
“All complaints and other information concerning potentially
defective products must be carefully reviewed according to
written procedures and corrective action should be taken.”
4. Module 5 | Slide 4 of 22 2012
5.2 – 5.3
Complaints and Recalls
Complaints Procedure - I
Designated responsible person:
To handle complaint
Decide on measure to be taken
May be authorized person - if not, must advise authorized
person of results
Sufficient support staff
Access to records
Written procedure (SOP):
Describes action to be taken
Includes need to consider a recall (e.g. possible product
defect)
5. Module 5 | Slide 5 of 22 2012
5.4 – 5.6
Complaints and Recalls
Complaints Procedure - II
Thorough investigation:
Quality Unit (e.g. QC) involved
With special attention as to whether suspect (counterfeit)
products may have been the cause
Fully record of detailed investigation
Due to product defect (discovered or suspected):
Consider checking other batches
Batches containing reprocessed product
6. Module 5 | Slide 6 of 22 2012
5.7 – 5.9
Complaints and Recalls
Complaints Procedure - III
Investigation and evaluation should result in appropriate follow-up
actions
May include a "recall"
All decisions and measures taken should be recorded
Referenced in batch records
Records reviewed at regular intervals
Also trending to be done to identify recurring problems
7. Module 5 | Slide 7 of 22 2012
5.10
Complaints and Recalls
Other actions
Inform competent authorities in case of serious quality
problems such as:
Faulty manufacture
Product deterioration
Suspect product
Serious quality problems
8. Module 5 | Slide 8 of 22 2012
Complaints and Recalls
Classification of Defects
If complaint is justified, then there has been a failure of the quality
system
Once the defect has been identified, the company should be
dealing with it in an appropriate way – which may include a recall
The definition of defects is useful
The following system has been found in some countries (Note: this
is not a WHO guideline):
Critical defects
Major defects
Other defects
9. Module 5 | Slide 9 of 22 2012
Complaints and Recalls
Critical Defects
Those defects which can be life-threatening and require the
company to take immediate action by all reasonable means,
whether in or out of business hours
Examples
Product labelled with incorrect name or incorrect strength
Counterfeit or deliberately tampered-with product
Microbiological contamination of a sterile product
10. Module 5 | Slide 10 of 22 2012
Complaints and Recalls
Major Defects
Those defects which may put the patient at some risk but are not
life-threatening and will require the batch recall or product
withdrawal within a few days
Examples
Any labelling/leaflet misinformation (or lack of information)
which represents a significant hazard to the patient
Microbial contamination of non-sterile products with some risk
for patients
Non-compliance to specifications (e.g. active ingredient assay)
11. Module 5 | Slide 11 of 22 2012
Complaints and Recalls
Other Defects
Those defects which present only a minor risk to the patient —
batch recall or product withdrawal would normally be initiated
within a few days
Examples
Readily visible isolated packaging/closure faults
Contamination which may cause spoilage or dirt and where
there is minimal risk to the patient
12. Module 5 | Slide 12 of 22 2012
Complaints and Recalls
Root Cause Analysis
It is also an increasing practise to do root cause
analysis (RCA) as part of the investigation of a
complaint
Use appropriate RCA tools to identify the reason(s) for
the failure or defect.
RCA assists in ensuring that appropriate corrective
action and preventive action (CAPA) is taken
13. Module 5 | Slide 13 of 22 2012
6.1
Complaints and Recalls
Recalls: Principle
“There should be a system to recall from the
market promptly and effectively, products known
or suspected to be defective.”
14. Module 5 | Slide 14 of 22 2012
Complaints and Recalls
Reasons for Recall may include:
Customer complaint
Detection of GMP failure after release
Result from the on-going stability testing
Request by the national authorities
Result of an inspection
Known counterfeiting or tampering
Adverse reaction reporting
15. Module 5 | Slide 15 of 22 2012
Complaints and Recalls
Definition
Recall
Removal from the market of specified batches of a product
May refer to one batch or all batches of product
16. Module 5 | Slide 16 of 22 2012
6.2
Complaints and Recalls
Recall Procedure - I
Designated responsible person (should be the "authorized
person")
To execute and coordinate recalls
Decide on measure to be taken
Sufficient support staff
To handle all aspects and urgency of recall
17. Module 5 | Slide 17 of 22 2012
6.3 – 6.4
Complaints and Recalls
SOP for Recall
Written and authorized SOP with detailed actions to
be taken
Regularly reviewed and updated
Capable of rapid operation to required level of
distribution chain, e.g. hospital and pharmacy level
Ensures that recalled products are kept in a secure,
segregated area
18. Module 5 | Slide 18 of 22 2012
6.6
Complaints and Recalls
Distribution Records
Distribution records available to authorized person and contain
sufficient information on:
Wholesalers
Direct customers
Export locations
Batch numbers and quantities
Including for clinical tests and medical samples
to permit effective recall
19. Module 5 | Slide 19 of 22 2012
6.5, 6.7, 6.8
Complaints and Recalls
Progress of recall
Inform all competent authorities of all countries where the given
product had been distributed
Monitor and record the progress during the recall
Final report should include reconciliation between delivered and
recovered products
Record of the disposition of the product
Effectiveness of procedure tested and evaluated from time
to time! (Mock recall)
20. Module 5 | Slide 20 of 22 2012
Complaints and Recalls
Group Session
Collect 3 examples of complaints or recalls from your
experience
Describe the actions to be taken by the company or authority
and the implications for all interested parties
Suggest a classification of the complaint or recall into critical
(life-threatening), major or other
21. Module 5 | Slide 21 of 22 2012
Complaints and Recalls
Possible Issues – I
No response to justified complaints
Response to unjustified complaints
Failure to recall
Failure to correct frequent complaints
No resources to investigate
No senior management support
Senior management interference
22. Module 5 | Slide 22 of 22 2012
Complaints and Recalls
Possible Issues – II
No distribution information/batch records
No access to records
Inability to contact government during holidays/weekends
Disagreement on severity of defect